These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3110794)

  • 41. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term study of fluvoxamine: a new rapid-acting antidepressant.
    Feldmann HS; Denber HC
    Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
    De Wilde JE; Mertens C; Wakelin JS
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):427S-431S. PubMed ID: 6407503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The tolerance and antidepressive activity of fluvoxamine as a single dose compared to a twice daily dose.
    Siddiqui UA; Chakravarti SK; Jesinger DK
    Curr Med Res Opin; 1985; 9(10):681-90. PubMed ID: 3935377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluvoxamine and chlorimipramine in endogenous depression.
    De Wilde JE; Doogan DP
    J Affect Disord; 1982 Sep; 4(3):249-59. PubMed ID: 6215443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.
    Klok CJ; Brouwer GJ; van Praag HM; Doogan D
    Acta Psychiatr Scand; 1981 Jul; 64(1):1-11. PubMed ID: 6172005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA; Arato M; Shrivastava R
    Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine.
    Coleman BS; Block BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):475-8. PubMed ID: 6819596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder.
    Cottraux J; Mollard E; Bouvard M; Marks I; Sluys M; Nury AM; Douge R; Cialdella P
    Int Clin Psychopharmacol; 1990 Jan; 5(1):17-30. PubMed ID: 2110206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluvoxamine-melatonin-stimulation-test (FMST) in patients with depressive disorders.
    Demisch L; Gerbaldo H; Demisch K
    Pharmacopsychiatry; 1988 Nov; 21(6):420-1. PubMed ID: 3149752
    [No Abstract]   [Full Text] [Related]  

  • 54. [Possible interaction between theophylline and fluvoxamine].
    Diot P; Jonville AP; Gerard F; Bonnelle M; Autret E; Breteau M; Lemarie E; Lavandier M
    Therapie; 1991; 46(2):170-1. PubMed ID: 1905066
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo.
    Cassano GB; Conti L; Massimetti G; Mengali F; Waekelin JS; Levine J
    Psychopharmacol Bull; 1986; 22(1):52-8. PubMed ID: 3088668
    [No Abstract]   [Full Text] [Related]  

  • 56. [Fantasy and reality: fluvoxamine. International symposium, Füssen, 4 May 1991].
    Nervenarzt; 1991 Jun; 62(6 Suppl):1-12. PubMed ID: 1906141
    [No Abstract]   [Full Text] [Related]  

  • 57. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.
    Pöldinger W; Calanchini B; Schwarz W
    Psychopathology; 1991; 24(2):53-81. PubMed ID: 1909444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluvoxamine: an antidepressant with low (or no) epileptogenic effect.
    Harmant J; van Rijckevorsel-Harmant K; de Barsy T; Hendrickx B
    Lancet; 1990 Aug; 336(8711):386. PubMed ID: 1975375
    [No Abstract]   [Full Text] [Related]  

  • 59. Mania and fluvoxamine.
    Burrai C; Bocchetta A; del Zompo M
    Am J Psychiatry; 1991 Sep; 148(9):1263-4. PubMed ID: 1909099
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluvoxamine in the treatment of menstrually related mood disorders.
    Veeninga AT; Westenberg HG; Weusten JT
    Psychopharmacology (Berl); 1990; 102(3):414-6. PubMed ID: 2123559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.